Cargando…

Shape and Phase Transitions in a PEGylated Phospholipid System

[Image: see text] Poly(ethylene glycol) (PEG) polymers and PEG-conjugated lipids are widely used in bioengineering and drug transport applications. A PEG layer in a drug carrier increases hydrophilic repulsion, inhibits membrane fusion and serum opsonin interactions, and prolongs the storage and cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Viitala, Lauri, Pajari, Saija, Gentile, Luigi, Määttä, Jukka, Gubitosi, Marta, Deska, Jan, Sammalkorpi, Maria, Olsson, Ulf, Murtomäki, Lasse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727609/
https://www.ncbi.nlm.nih.gov/pubmed/30789270
http://dx.doi.org/10.1021/acs.langmuir.8b03829
_version_ 1783449289814441984
author Viitala, Lauri
Pajari, Saija
Gentile, Luigi
Määttä, Jukka
Gubitosi, Marta
Deska, Jan
Sammalkorpi, Maria
Olsson, Ulf
Murtomäki, Lasse
author_facet Viitala, Lauri
Pajari, Saija
Gentile, Luigi
Määttä, Jukka
Gubitosi, Marta
Deska, Jan
Sammalkorpi, Maria
Olsson, Ulf
Murtomäki, Lasse
author_sort Viitala, Lauri
collection PubMed
description [Image: see text] Poly(ethylene glycol) (PEG) polymers and PEG-conjugated lipids are widely used in bioengineering and drug transport applications. A PEG layer in a drug carrier increases hydrophilic repulsion, inhibits membrane fusion and serum opsonin interactions, and prolongs the storage and circulation time. It can also change the carrier shape and have an influence on many properties related to the content release of the carrier. In this paper, we focus on the physicochemical effects of PEGylation in the lipid bilayer. We introduce laurdanC as a fluorophore for shape recognition and phase transition detection. Together with laurdanC, cryogenic transmission electron microscopy, differential scanning calorimetry, molecular dynamics simulations, and small-angle X-ray scattering/wide-angle X-ray scattering, we acquire information of the particle/bilayer morphology and phase behavior in systems containing 1,2-dipalmitoyl-sn-glycero-3-phosphocholine:1,2-distearoyl-sn-glycero-3-phosphoethanolamine-PEG(2000) with different fractions. We find that PEGylation leads to two important and potentially usable features of the system. (1) Spherical vesicles present a window of elevated chain-melting temperatures and (2) lipid packing shape-controlled liposome-to-bicelle transition. The first finding is significant for targets requiring multiple release sequences and the second enables tuning the release by composition and the PEG polymer length. Besides drug delivery systems, the findings can be used in other smart soft materials with trigger-polymers as well.
format Online
Article
Text
id pubmed-6727609
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-67276092019-09-06 Shape and Phase Transitions in a PEGylated Phospholipid System Viitala, Lauri Pajari, Saija Gentile, Luigi Määttä, Jukka Gubitosi, Marta Deska, Jan Sammalkorpi, Maria Olsson, Ulf Murtomäki, Lasse Langmuir [Image: see text] Poly(ethylene glycol) (PEG) polymers and PEG-conjugated lipids are widely used in bioengineering and drug transport applications. A PEG layer in a drug carrier increases hydrophilic repulsion, inhibits membrane fusion and serum opsonin interactions, and prolongs the storage and circulation time. It can also change the carrier shape and have an influence on many properties related to the content release of the carrier. In this paper, we focus on the physicochemical effects of PEGylation in the lipid bilayer. We introduce laurdanC as a fluorophore for shape recognition and phase transition detection. Together with laurdanC, cryogenic transmission electron microscopy, differential scanning calorimetry, molecular dynamics simulations, and small-angle X-ray scattering/wide-angle X-ray scattering, we acquire information of the particle/bilayer morphology and phase behavior in systems containing 1,2-dipalmitoyl-sn-glycero-3-phosphocholine:1,2-distearoyl-sn-glycero-3-phosphoethanolamine-PEG(2000) with different fractions. We find that PEGylation leads to two important and potentially usable features of the system. (1) Spherical vesicles present a window of elevated chain-melting temperatures and (2) lipid packing shape-controlled liposome-to-bicelle transition. The first finding is significant for targets requiring multiple release sequences and the second enables tuning the release by composition and the PEG polymer length. Besides drug delivery systems, the findings can be used in other smart soft materials with trigger-polymers as well. American Chemical Society 2019-02-21 2019-03-19 /pmc/articles/PMC6727609/ /pubmed/30789270 http://dx.doi.org/10.1021/acs.langmuir.8b03829 Text en Copyright © 2019 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Viitala, Lauri
Pajari, Saija
Gentile, Luigi
Määttä, Jukka
Gubitosi, Marta
Deska, Jan
Sammalkorpi, Maria
Olsson, Ulf
Murtomäki, Lasse
Shape and Phase Transitions in a PEGylated Phospholipid System
title Shape and Phase Transitions in a PEGylated Phospholipid System
title_full Shape and Phase Transitions in a PEGylated Phospholipid System
title_fullStr Shape and Phase Transitions in a PEGylated Phospholipid System
title_full_unstemmed Shape and Phase Transitions in a PEGylated Phospholipid System
title_short Shape and Phase Transitions in a PEGylated Phospholipid System
title_sort shape and phase transitions in a pegylated phospholipid system
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727609/
https://www.ncbi.nlm.nih.gov/pubmed/30789270
http://dx.doi.org/10.1021/acs.langmuir.8b03829
work_keys_str_mv AT viitalalauri shapeandphasetransitionsinapegylatedphospholipidsystem
AT pajarisaija shapeandphasetransitionsinapegylatedphospholipidsystem
AT gentileluigi shapeandphasetransitionsinapegylatedphospholipidsystem
AT maattajukka shapeandphasetransitionsinapegylatedphospholipidsystem
AT gubitosimarta shapeandphasetransitionsinapegylatedphospholipidsystem
AT deskajan shapeandphasetransitionsinapegylatedphospholipidsystem
AT sammalkorpimaria shapeandphasetransitionsinapegylatedphospholipidsystem
AT olssonulf shapeandphasetransitionsinapegylatedphospholipidsystem
AT murtomakilasse shapeandphasetransitionsinapegylatedphospholipidsystem